| 美罗华联合CHOP方案治疗B细胞性非霍奇金淋巴瘤的临床观察 |
| |
| 引用本文： | 古健,陈焯文.美罗华联合CHOP方案治疗B细胞性非霍奇金淋巴瘤的临床观察[J].中外医疗,2011,30(16):9-10. |
| |
| 作者姓名： | 古健 陈焯文 |
| |
| 作者单位： | 广东省佛山市第一人民医院,广东,佛山,528000 |
| |
| 摘 要： | 目的观察美罗华联合CHOP方案治疗CD20阳性B细胞性非霍奇金淋巴瘤的临床疗效及不良反应。方法回顾性分析我科采用美罗华联合化疗治疗13例B细胞非霍奇金淋巴瘤的疗效及影响因素。结果完全缓解率69.2%（9/13）,部分缓解（PR）23%（3/13）,总有效率92.3%（12/13）。结论美罗华联合CHOP方案治疗B细胞性非霍奇金淋巴瘤疗效好,且未增加不良反应。
|
| 关 键 词： | 美罗华 非霍奇金淋巴瘤 治疗 |
Clinical Observeion of Rituximab Combined with CHOP in Treatment of B cell Non-Hodgkin's Lymphoma |
| |
| GU Jian,CHEN Zhuowen.Clinical Observeion of Rituximab Combined with CHOP in Treatment of B cell Non-Hodgkin's Lymphoma[J].China Foreign Medical Treatment,2011,30(16):9-10. |
| |
| Authors: | GU Jian CHEN Zhuowen |
| |
| Institution: | GU Jian CHEN Zhuowen |
| |
| Abstract: | Objective To observe the therapeutic effects and side-effects of Rituximab combined with CHOP in treatment of B cell non-Hodgkin＇s lymphoma.Methods We retrospectively analyzed the data from13patients with B-NHL who underwent Rituximab combined with chemotherapy in our hospital.Results The complete response（CR）rate was69.2%（9/13）,the partial response（PR）rate was23%（3/13）,and the overall response rate was92.3%（12/13）.Conclusion Rituximab-containing chemotherapeutic regimens are effective for native B-NHL with mild side-effective. |
| |
| Keywords: | Rituximad Non-Hodgkin＇s lymphoma Treatment |
| 本文献已被 维普 万方数据 等数据库收录！ |
